ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients

By Liem A. H.   van de Woestijne A. P.   Roeters van Lennep H. W. O.   Zwinderman A. H.   van der Steeg W. A.   Jukema J. W.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 359-364

Informa Healthcare

Access to resources Recommend Favorite

Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs—apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes

By Niemi Jaakko   Makinen Ville-Petteri   Heikkonen Jukka   Tenkanen Leena   Hiltunen Yrjo   Hannuksela Minna   Jauhiainen Matti   Forsblom Carol   Taskinen Marja-Riitta   Kesaniemi Y. Antero   Savolainen Markku   Kaski Kimmo   Groop Per-Henrik   Kovanen Petri   Ala-Korpela Mika  

Annals of Medicine, Vol. 41, Iss. 6, 2009-01 ,pp. : 451-461

Informa Healthcare

Access to resources Recommend Favorite

ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management*

By de Nijs Tjerk   Sniderman Allan   de Graaf Jacqueline  

Critical Reviews in Clinical Laboratory Sciences, Vol. 50, Iss. 6, 2013-11 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL

By Zannis Vassilis   Chroni Angeliki   Krieger Monty  

Journal of Molecular Medicine, Vol. 84, Iss. 4, 2006-04 ,pp. : 276-294

Springer Publishing Company

Access to resources Recommend Favorite

Non-HDL cholesterol, ApoB and LDL particle concentration in coronary heart disease risk prediction and treatment

By Orringer Carl E  

Clinical Lipidology, Vol. 8, Iss. 1, 2013-02 ,pp. : 69-79

Future Medicine

Access to resources Recommend Favorite